Suppr超能文献

韩国小肝细胞癌的系统性肝切除术

Systematic hepatectomy for small hepatocellular carcinoma in Korea.

作者信息

Suh Kyung-Suk

机构信息

Department of Surgery, College of Medicine, Seoul National University, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea.

出版信息

J Hepatobiliary Pancreat Surg. 2005;12(5):365-70. doi: 10.1007/s00534-005-1002-3.

Abstract

BACKGROUND/PURPOSE: Systematic hepatectomy for small hepatocellular carcinoma (HCC) is a widely preferred modality, but evidence concerning its benefits is lacking. The aim of this study was to document hepatic resection for small HCC in Korea, and to determine whether patient survival or the pattern of tumor recurrence was influenced by the methods used.

METHODS

Ten major hospitals that perform hepatectomy for HCC in Korea were surveyed for surgeons' opinions concerning systematic hepatectomy and current trends in hepatic resection for small HCC. An analysis was also performed of 119 patients who underwent curative hepatectomy for small HCC (size < 5 cm) between January 2000 and December 2002 at Seoul National University Hospital. Seventy-four of these 119 patients underwent anatomical resection (AR) and 45 had a non-anatomical resection (NAR). Recurrence-free survival, recurrence pattern, overall survival rates, and the risk factors for recurrence were analyzed.

RESULTS

In the survey, eight of ten surgeons preferred systematic hepatectomy and considered it to aid prognosis. No significant difference was found between the AR and NAR groups in terms of the clinicopathologic findings, except that the presence of underlying hepatic cirrhosis was more prevalent in the NAR group. The postoperative morbidity rate was higher in the NAR group (33.3% vs 27.0%), but this difference was not statistically significant. The respective 1- and 3-year recurrence-free survival rates were 78.1% and 49.7% in the AR group, and 68.9% and 46.5% in the NAR group (P > 0.05). The corresponding 1- and 3-year overall survival rates were 88.8% and 80.8% in the AR group and 91.0% and 71.4% in the NAR group (P > 0.05).

CONCLUSIONS

Although systematic hepatectomy seems to be superior to non-anatomical hepatectomy from the oncological and anatomical aspects, this superiority is not reflected by the recurrence patterns or the survival and recurrence rates of the two procedures. Postoperative recurrence appears, rather, to be related to the underlying liver condition.

摘要

背景/目的:对于小肝细胞癌(HCC),系统性肝切除术是一种广泛采用的术式,但关于其益处的证据尚不充分。本研究旨在记录韩国小HCC肝切除术的情况,并确定患者生存情况或肿瘤复发模式是否受所采用方法的影响。

方法

对韩国十家主要开展HCC肝切除术的医院进行调查,了解外科医生对系统性肝切除术的看法以及小HCC肝切除术的当前趋势。同时,对2000年1月至2002年12月在首尔国立大学医院接受小HCC(直径<5 cm)根治性肝切除术的119例患者进行分析。这119例患者中,74例行解剖性肝切除术(AR),45例行非解剖性肝切除术(NAR)。分析无复发生存率、复发模式、总生存率及复发的危险因素。

结果

在调查中,十位外科医生中有八位倾向于系统性肝切除术,并认为其有助于改善预后。除NAR组潜在肝硬化更为常见外,AR组和NAR组在临床病理特征方面未发现显著差异。NAR组术后发病率较高(33.3%对27.0%),但差异无统计学意义。AR组1年和3年无复发生存率分别为78.1%和49.7%,NAR组分别为68.9%和46.5%(P>0.05)。AR组1年和3年总生存率分别为88.8%和80.8%,NAR组分别为91.0%和71.4%(P>0.05)。

结论

尽管从肿瘤学和解剖学角度看,系统性肝切除术似乎优于非解剖性肝切除术,但两种术式的复发模式、生存率和复发率并未体现出这种优势。术后复发似乎与潜在肝脏状况有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验